These data, taken together, indicate the thyroid-specific Usp44 knockout accelerates the progression of BRAFV600E-induced thyroid cancer, further highlighting the role of USP44 as a tumor suppressor in thyroid cancer. Here, USP44 is linked to neoplasm.